Saturn V Capital Management »

Neumora Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.8M 390k 9.83

More positions owned by Saturn V Capital Management

Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Crinetics Pharmaceuticals In (CRNX)
Vaxcyte (PCVX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Cytokinetics Com New (CYTK)
BioMarin Pharmaceutical (BMRN)
Cogent Biosciences (COGT)
Cargo Therapeutics (CRGX)
Kalvista Pharmaceuticals (KALV)
Celcuity (CELC)
Merus N V (MRUS)
Syndax Pharmaceuticals (SNDX)
Abivax Sa Sponsored Ads (ABVX)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Saturn V Capital Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics